Purple Biotech (PPBT) Operating Leases (2018 - 2021)

Purple Biotech (PPBT) has disclosed Operating Leases for 4 consecutive years, with $550000.0 as the latest value for Q4 2021.

  • On a quarterly basis, Operating Leases fell 20.06% to $550000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $550000.0, a 20.06% decrease, with the full-year FY2021 number at $550000.0, down 20.06% from a year prior.
  • Operating Leases was $550000.0 for Q4 2021 at Purple Biotech, down from $688000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $688000.0 in Q4 2020 to a low of $28000.0 in Q4 2019.
  • A 4-year average of $416500.0 and a median of $475000.0 in 2018 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: tumbled 93.0% in 2019, then soared 2357.14% in 2020.
  • Purple Biotech's Operating Leases stood at $400000.0 in 2018, then crashed by 93.0% to $28000.0 in 2019, then skyrocketed by 2357.14% to $688000.0 in 2020, then decreased by 20.06% to $550000.0 in 2021.
  • Per Business Quant, the three most recent readings for PPBT's Operating Leases are $550000.0 (Q4 2021), $688000.0 (Q4 2020), and $28000.0 (Q4 2019).